STAT3 silencing enhances the efficacy of the HSV.tk suicide gene in gastrointestinal cancer therapy

Development of microRNA-145 for therapeutic application in breast cancer

(2011) Seok-Jun Kim et al.   JOURNAL OF CONTROLLED RELEASE

Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2Kb-restricted T cell epitope

(2009) Jung-Sun Park et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

(2009) Teak-Chin Cheong et al.   CANCER SCIENCE

STAT3 as a prognostic marker in human gastric cancer

(2009) Cameron B Jackson et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Expression of retinoblastoma and cyclin D1 in gastric carcinoma

(2009) D. Arici et al.   NEOPLASMA

Role of Stat3 in suppressing anti-tumor immunity

(2008) Marcin Kortylewski et al.   CURRENT OPINION IN IMMUNOLOGY

Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts

(2008) James E. Littlejohn et al.   INTERNATIONAL JOURNAL OF CANCER

Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas

(2008) E. C. Brantley et al.   MOLECULAR CANCER RESEARCH

STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5′ and 3′ ends

(2008) H. Dan Lewis et al.   MOLECULAR CANCER THERAPEUTICS

miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy

(2008) Takayuki Suzuki et al.   MOLECULAR THERAPY